SQZ Biotechnologies Price to Book Ratio 2020-2023 | SQZ
Historical price to book ratio values for SQZ Biotechnologies (SQZ) over the last 10 years. The current price to book ratio for SQZ Biotechnologies as of May 29, 2023 is 0.42.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| SQZ Biotechnologies Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2023-05-30 |
0.55 |
|
0.40 |
| 2023-03-31 |
0.56 |
$1.36 |
0.41 |
| 2022-12-31 |
0.74 |
$1.94 |
0.38 |
| 2022-09-30 |
2.28 |
$2.34 |
0.98 |
| 2022-06-30 |
3.18 |
$3.03 |
1.05 |
| 2022-03-31 |
4.81 |
$3.73 |
1.29 |
| 2021-12-31 |
8.93 |
$4.41 |
2.03 |
| 2021-09-30 |
14.42 |
$4.75 |
3.04 |
| 2021-06-30 |
14.45 |
$5.45 |
2.65 |
| 2021-03-31 |
13.68 |
$6.07 |
2.25 |
| 2020-12-31 |
28.98 |
$5.13 |
5.65 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.017B |
$0.021B |
|
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
|
